Published in Lancet on March 12, 1977
Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ (1978) 9.23
A case of Ebola virus infection. Br Med J (1977) 7.40
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ (1978) 5.82
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature (2008) 5.24
Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol (1998) 5.16
Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol (2003) 4.67
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Social inequalities and emerging infectious diseases. Emerg Infect Dis (1997) 2.95
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror (2011) 2.62
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol (1982) 2.44
Ebola virus pathogenesis: implications for vaccines and therapies. J Virol (2003) 2.25
Ethical and practical considerations in providing critical care to patients with Ebola virus disease. Chest (2015) 2.05
Plaque assay for Ebola virus. J Clin Microbiol (1981) 1.99
Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J Virol (2007) 1.97
Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol (1984) 1.78
Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis (2004) 1.76
Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga. J Venom Anim Toxins Incl Trop Dis (2014) 1.72
Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells. J Virol (1999) 1.68
Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol (2001) 1.66
Modern uses of electron microscopy for detection of viruses. Clin Microbiol Rev (2009) 1.63
Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest (1993) 1.57
Optofluidic analysis system for amplification-free, direct detection of Ebola infection. Sci Rep (2015) 1.40
Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J Clin Microbiol (2001) 1.39
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic. Cell (2016) 1.35
Emerging infections: getting ahead of the curve. Emerg Infect Dis (1996) 1.29
Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Arch Virol (2014) 1.27
Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol (2006) 1.26
Ultrastructure of Ebola virus particles in human liver. J Clin Pathol (1978) 1.25
Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples. Genome Biol (2014) 1.16
Ebola virus: a comparison, at ultrastructural level, of the behaviour of the Sudan and Zaire strains in monkeys. Br J Exp Pathol (1978) 1.16
Virion nucleic acid of Ebola virus. J Virol (1980) 1.15
Investigation of Ebola VP40 assembly and oligomerization in live cells using number and brightness analysis. Biophys J (2012) 1.14
Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain. J Mol Biol (2007) 1.14
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat Rev Microbiol (2015) 1.07
The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress. J Biol Chem (2013) 1.07
Inhibition of heat-shock protein 90 reduces Ebola virus replication. Antiviral Res (2010) 1.04
Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency. Clin Infect Dis (2015) 1.01
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity. Genome Biol (2014) 1.01
The Ebola virus matrix protein deeply penetrates the plasma membrane: an important step in viral egress. Biophys J (2013) 0.99
Experimental Inoculation of Egyptian Rousette Bats (Rousettus aegyptiacus) with Viruses of the Ebolavirus and Marburgvirus Genera. Viruses (2015) 0.99
[The epidemic of Ebola haemorrhagic fever in Sudan and Zaire, 1976: introductory note]. Bull World Health Organ (1978) 0.99
Epidemiologic data and pathogen genome sequences: a powerful synergy for public health. Genome Biol (2014) 0.95
Immunofluorescence method for detection of Ebola virus immunoglobulin g, using HeLa cells which express recombinant nucleoprotein. J Clin Microbiol (2001) 0.95
Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom (2010) 0.95
Membrane binding and bending in Ebola VP40 assembly and egress. Front Microbiol (2014) 0.95
Natural experimental models: the global search for biomedical paradigms among traditional, modernizing, and modern populations. Proc Natl Acad Sci U S A (1999) 0.93
Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression. PLoS Negl Trop Dis (2011) 0.92
A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection. Mol Pharm (2014) 0.90
Cell culture and electron microscopy for identifying viruses in diseases of unknown cause. Emerg Infect Dis (2013) 0.89
Ebola, the killer virus. Infect Dis Poverty (2015) 0.89
Forty years of the war against Ebola. J Zhejiang Univ Sci B (2014) 0.89
Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med Microbiol Immunol (2003) 0.88
Transmission Dynamics and Final Epidemic Size of Ebola Virus Disease Outbreaks with Varying Interventions. PLoS One (2015) 0.88
"Filoviruses": a real pandemic threat? EMBO Mol Med (2009) 0.88
Ebola virus disease: from epidemiology to prophylaxis. Mil Med Res (2015) 0.87
Performance of bedside diagnostic ultrasound in an Ebola isolation unit: the Emory University Hospital experience. AJR Am J Roentgenol (2015) 0.87
Bats and zoonotic viruses: can we confidently link bats with emerging deadly viruses? Mem Inst Oswaldo Cruz (2015) 0.87
The Ebola virus matrix protein VP40 selectively induces vesiculation from phosphatidylserine-enriched membranes. J Biol Chem (2014) 0.86
Molecular docking based screening of predicted potential inhibitors for VP40 from Ebola virus. Bioinformation (2015) 0.83
Ebola viral disease outbreak-2014: implications and pitfalls. Front Public Health (2014) 0.82
Recovery potential of a western lowland gorilla population following a major Ebola outbreak: results from a ten year study. PLoS One (2012) 0.82
Diagnosis of Ebola Virus Disease: Past, Present, and Future. Clin Microbiol Rev (2016) 0.82
Emerging and re-emerging viruses: A global challenge illustrated by Chikungunya virus outbreaks. World J Virol (2012) 0.81
Ebola virus: a clear and present danger. J Clin Microbiol (2014) 0.81
Using European travellers as an early alert to detect emerging pathogens in countries with limited laboratory resources. BMC Public Health (2007) 0.80
One-Step Reverse-Transcription FRET-PCR for Differential Detection of Five Ebolavirus Species. PLoS One (2015) 0.79
Ebola virus transmission. Int J Exp Pathol (1995) 0.79
New global viral threats. Saudi Med J (2015) 0.78
Ebola virus disease: an update for anesthesiologists and intensivists. Can J Anaesth (2014) 0.77
Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016. J Infect Dis (2016) 0.76
Effective binding of a phosphatidylserine-targeting antibody to Ebola virus infected cells and purified virions. J Immunol Res (2015) 0.76
Lassa, Marburg and Ebola: newly described African fevers. Can Med Assoc J (1978) 0.76
Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism. Viruses (2015) 0.76
Diagnostics in Ebola Virus Disease in Resource-Rich and Resource-Limited Settings. PLoS Negl Trop Dis (2016) 0.75
The transition from a rural to an urban environment alters expression of the human Ebola virus receptor Neiman-Pick C1: implications for the current epidemic in West Africa. Cell Stress Chaperones (2014) 0.75
Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein. J Virol (2016) 0.75
Leading the charge: Médecins Sans Frontières receives the 2015 Lasker~Bloomberg Public Service Award. J Clin Invest (2015) 0.75
Comparison of the Aerosol Stability of 2 Strains of Zaire ebolavirus From the 1976 and 2013 Outbreaks. J Infect Dis (2016) 0.75
Etymologia. Ebola. Emerg Infect Dis (2015) 0.75
Cellular factors implicated in filovirus entry. Adv Virol (2013) 0.75
The enigmatic haemorrhagic fevers. J R Soc Med (1997) 0.75
The socio-economic drivers of bushmeat consumption during the West African Ebola crisis. PLoS Negl Trop Dis (2017) 0.75
The Role of Cytokines and Chemokines in Filovirus Infection. Viruses (2015) 0.75
Indirect immunofluorescence for the diagnosis of Lassa fever infection. Bull World Health Organ (1975) 6.81
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis (1978) 4.95
A plaque neutralization method for arboviruses. Proc Soc Exp Biol Med (1967) 4.27
The child PTSD Symptom Scale: a preliminary examination of its psychometric properties. J Clin Child Psychol (2001) 4.00
Marburg-virus disease in Kenya. Lancet (1982) 3.79
Comparative electrophoretic analysis of the virus proteins of four rhabdoviruses. J Gen Virol (1974) 3.74
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Segmented genome and nucleocapsid of La Crosse virus. J Virol (1976) 3.25
Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal. Prog Med Virol (1967) 3.22
Effect of surveillance on the number of hysterectomies in the province of Saskatchewan. N Engl J Med (1977) 3.04
Nosocomial outbreak of viral hemorrhagic fever caused by Crimean Hemorrhagic fever-Congo virus in Pakistan, January 1976. Am J Trop Med Hyg (1980) 3.00
Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance. Am J Epidemiol (1969) 2.91
Structural proteins of La Crosse virus. J Virol (1976) 2.90
Two African viruses serologically and morphologically related to rabies virus. J Virol (1970) 2.62
A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group. J Acquir Immune Defic Syndr (1990) 2.57
Dissolved organic matter and heterotrophic microneuston in the surface microlayers of the north atlantic. Science (1976) 2.54
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol (1982) 2.44
Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis (1982) 2.42
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis (1980) 2.38
Immunopathology of lymphocytic choriomeningitis viurs infection of newborn mice. Antithymocyte serum effects on glomerulonephritis and wasting disease. J Exp Med (1968) 2.31
Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis (1980) 2.30
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
Comparative pathogenesis of rabies and rabies-like viruses. Viral infection and transit from inoculation site to the central nervous system. Lab Invest (1973) 2.13
Venezuelan equine encephalitis. Adv Vet Sci Comp Med (1974) 2.12
Immune tolerance in Calomys callosus infected with Machupo virus. Nature (1969) 2.00
Proposed antigenic classification of registered arboviruses I. Togaviridae, Alphavirus. Intervirology (1980) 1.98
Agent of disease contracted from green monkeys. Science (1968) 1.98
Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis (1983) 1.94
Arenoviruses in Vero cells: ultrastructural studies. J Virol (1970) 1.91
Rabies pathogenesis. Arch Virol (1977) 1.91
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
Effects of anti-lymphoid sera on viral infections. Lancet (1968) 1.87
Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis. Bull World Health Organ (1975) 1.83
Morphological comparison of Machupo with lymphocytic choriomeningitis virus: basis for a new taxonomic group. J Virol (1969) 1.82
The measurement of specific antibodies in Bolivian hemorrhagic fever by neutralization of virus plaques. Proc Soc Exp Biol Med (1969) 1.82
Arenoviruses: proposed name for a newly defined virus group. J Virol (1970) 1.81
Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections. Bull World Health Organ (1979) 1.80
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Physiocochemical and serological studies. J Gen Virol (1971) 1.78
Hemagglutinin of rabies and some other bullet-shaped viruses. Proc Soc Exp Biol Med (1968) 1.74
Effects of anti-thymocyte serum on lymphocytic choriomeningitis (LCM) virus infection in mice. Proc Soc Exp Biol Med (1967) 1.71
Marburg virus infection in monkeys. Ultrastructural studies. Lab Invest (1971) 1.71
Bunyaviridae: morphologic and morphogenetic similarities of Bunyamwera serologic supergroup viruses and several other arthropod-borne viruses. Intervirology (1973) 1.70
Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol (1996) 1.69
Electron microscopic and antigenic studies of uncharacterized viruses. II. Evidence suggesting the placement of viruses in the family Bunyaviridae. Arch Virol (1989) 1.67
St. Louis encephalitis virus infection in mice. Electron microscopic studies of central nervous system. Lab Invest (1968) 1.64
Parainfluenza virus Sendai infection in macrophages, ependyma, choroid plexus, vascular endothelium and respiratory tract of mice. Am J Pathol (1973) 1.63
Bunyaviridae: recent biochemical developments. J Gen Virol (1977) 1.61
Intraocular use of rituximab. Eye (Lond) (2007) 1.58
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies. J Gen Virol (1971) 1.56
Ebola virus: identification of virion structural proteins. J Gen Virol (1980) 1.54
Epiphyseal union of the anterior iliac crest and medial clavicle in a modern multiracial sample of American males and females. Am J Phys Anthropol (1985) 1.54
Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in south-east Africa. Bull World Health Organ (1977) 1.53
Chronic infection of rodents by Machupo virus. Science (1965) 1.52
Pathology and pathogenesis of arenavirus infections. Curr Top Microbiol Immunol (1987) 1.52
Ecologic studies of vesicular stomatitis virus. I. Prevalence of infection among animals and humans living in an area of endemic VSV activity. Am J Epidemiol (1969) 1.52
Detection of DNA and RNA virus genomes in organ systems of whole mice: patterns of mouse organ infection by polyomavirus. J Virol (1984) 1.50
Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus. J Infect Dis (1973) 1.50
California group arboviruses: immunodiffusion studies. J Immunol (1967) 1.48
Morphology and morphogenesis of arenaviruses. Bull World Health Organ (1975) 1.46
Vesicular stomatitis virus (Indiana serotype): transovarial transmission by phlebotomine sandlies. Science (1972) 1.42
Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem (1988) 1.42
The reticuloendothelium as the target in a virus infection. Pichinde virus pathogenesis in two strains of hamsters. Lab Invest (1977) 1.41
The binding of staphylococcal protein A by the sera of different animal species. J Immunol (1982) 1.40
Unilateral versus bilateral thyroid resection in differentiated thyroid carcinoma. Can J Surg (1992) 1.39
Epidemiology of Machupo virus infection. 3. Significance of virological observations in man and animals. Am J Trop Med Hyg (1965) 1.39
An exotic viral disease acquired in a laboratory. N Engl J Med (1995) 1.38
An outbreak of Venezuelan equine encephalomeylitis in Central America. Evidence for exogenous source of a virulent virus subtype. Am J Epidemiol (1971) 1.37
Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness. J Exp Med (1968) 1.36
Serological relationship of the Tacaribe complex of viruses to lymphocytic choriomeningitis virus. J Virol (1970) 1.35
Recovery of Venezuelan equine encephalomyelitis virus in Panama. A fatal case in man. Am J Trop Med Hyg (1968) 1.35
The interferon refractory state: in vivo and in vitro studies of its mechanism. J Immunol (1971) 1.34
Clinical and serological response to laboratory-acquired human infection by Indiana type vesicular stomatitis virus (VSV). Am J Trop Med Hyg (1966) 1.34
Crystal structure of a diabody, a bivalent antibody fragment. Structure (1994) 1.32
Viral pancreatitis: ultrastructural pathological effects of Coxsackievirus B3 infection in newborn mouse pancreas. Exp Mol Pathol (1972) 1.32
The circular, segmented nucleocapsid of an arenavirus-Tacaribe virus. J Gen Virol (1977) 1.32